Skip to content
  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    EHC 2022
    AES 2022
    WSC 2022
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Elias Sotirchos

GFAP: a potential biomarker for progression in MS 1:31
GFAP: a potential biomarker for progression in MS
Elias Sotirchos • 27 Feb 2023
Longitudinal studies to bring sNfL to MS clinical practice 1:13
Longitudinal studies to bring sNfL to MS clinical practice
Elias Sotirchos • 27 Feb 2023
Interpretation of serum NfL depends on the selection of a reference population 4:41
Interpretation of serum NfL depends on the selection of a reference population
Elias Sotirchos • 27 Feb 2023
Retinal atrophy independent of optic neuritis in AQP4+ NMOSD 6:47
Retinal atrophy independent of optic neuritis in AQP4+ NMOSD
Elias Sotirchos • 18 Oct 2021
Elevated sNfL associated with brain atrophy and new T2 lesions 4:26
Elevated sNfL associated with brain atrophy and new T2 lesions
Elias Sotirchos • 18 Oct 2021
Serum neurofilament light chain levels as a biomarker in MS 4:48
Serum neurofilament light chain levels as a biomarker in MS
Elias Sotirchos • 23 Feb 2021
ACTRIMS highlights: aging, emerging concepts, and visual pathways 1:13
ACTRIMS highlights: aging, emerging concepts, and visual pathways
Elias Sotirchos • 23 Feb 2021
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS 2:28
Assessing novel biomarkers: retinal layer atrophy in PMS vs. RRMS
Elias Sotirchos • 23 Feb 2021
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy